{"name":"Verve Medical, Inc","slug":"verve-medical-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Active hypertension medical therapy","genericName":"Active hypertension medical therapy","slug":"active-hypertension-medical-therapy","indication":"Hypertension","status":"phase_1"}]}],"pipeline":[{"name":"Active hypertension medical therapy","genericName":"Active hypertension medical therapy","slug":"active-hypertension-medical-therapy","phase":"phase_1","mechanism":"Blocks the action of angiotensin II at the AT1 receptor","indications":["Hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1SLUtGTW5vM1JsbktCUjBLemxGdG80Mi1WemI5VHg1MF9lTFdaX3k0d3dfd3BiWGRBZEdKd0xHd2RKa29KYlFKSFh3ZWpINjlNRG5hazlBN0t1Rlc5eHF2Uk4zbXFwaER5eE5DQ3lsdkZ2bGE2eU9vVUVRNEVCZlU?oc=5","date":"2026-01-07","type":"pipeline","source":"MassDevice","summary":"Medtronic expands US pharmacy formulary access for MiniMed 780G - MassDevice","headline":"Medtronic expands US pharmacy formulary access for MiniMed 780G","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNc2M1RG5lbkJyNjViVnJIa3NxaTZhaVZFdXBrYXpDdEFKRGpfYkVaZkRjNXl2Nm40LWhsQ0QySUxzb2lQSWtPTHJfRXh3Qnp6OUI0OVNUWm9NbDM1VUVKaUZDN3hPOUZudlVQeUp2ZkdoQXFGWG5mY29UUXhEWVZBcmlHN2pIc0pLN0tkN29IUmtIMEkzTENCZTlIY05SZ1Z6OTBWblJ4dE5GMVU?oc=5","date":"2025-12-09","type":"pipeline","source":"European Medical Journal","summary":"Renal Denervation at ESC 2025: Updates and Insights - European Medical Journal","headline":"Renal Denervation at ESC 2025: Updates and Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOaDl3V3NtVUxybDNYSjQzSWs2QXE0VkhHQjNlN3pjbVdsdm9ldzF6bXFxZXI5bEt6SnlsQ0lPT2VsdDdTeDlwRUJSWXVzeFBYTjVKaFAzeHpoWFRqRlZlZld4dGNqS01pM1RJR0VGNmo4cUtmUTlqYzZTRTE4elE3VUtQWGw?oc=5","date":"2025-07-10","type":"pipeline","source":"Yahoo Finance","summary":"Verve Therapeutics, Inc. (VERV): A Bull Case Theory - Yahoo Finance","headline":"Verve Therapeutics, Inc. (VERV): A Bull Case Theory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPWG5nR1hNQTYzVmo1bzZDUzM0LWRqeUZDeTUzVUNGdFE1cmxHOU81bHluNVZ1QTJmcnprSmFmV1ZVU091b3hLQnlQS2xjVm15YU1mamJpbDNwNlpfckpGN0dISTRGQVVfQzhpMTFEUXl2Q0xOSU5tOXREODZ2ZHprWHdFRFhRQ244Z2JhenpQZ05OUVFuMnE0ejNCRTBWengtX1VsaWk1TDFVcUhSdDVJZ2lXYk1nZi1OS3Vjb3diZw?oc=5","date":"2025-06-17","type":"deal","source":"Eli Lilly","summary":"Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - Eli Lilly","headline":"Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxOUDdrUFhJdXlLSjRaVFlFM0pMLUYxZ3ZmV3RkYUhZaXRLeFpmd3ZTVlN3eElodnNiM3pKcEg0cDI0ejZmNmxVVklVcUhiTElPbG1rTzJzX0g3Q2pyOXRKVTRqNHh5SWJoQURTWFFnNFBMell0TkxIYU9EalpSX0kyQ2JKWHNrSHZnYTl4ZktqbGFjVFJyWW04dlYzWFEtWXZENDF1bjVYdDNhVXNXOWQwOG1SMDVoRHZtbHpxRXVjbXZCTU5mYlUtMzJhcm5fTk9HbWNWbGJJbjg0LTBqRUdB?oc=5","date":"2025-06-17","type":"deal","source":"Reuters","summary":"Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push - Reuters","headline":"Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPM0RQX0tLV0dMdjRYZ1ItV3NiLXQwcDlGeGNQbjRKeG96dE9kSnRoZkY3M1N6d3ljblZLbVpPbkNzRV9mMXBOc19Ebk9sZUJXajU0QWlnZVp6aEFwQ3ZYVXR4bTRsWGNsYkR6THNBMzdSaTdTdUM4SHk1SmRZUW1WVDdKTUlqdFhwZHJBdnVPSTVlc1dVTHV4S2twTjl5aHdIMlF0V2wwOA?oc=5","date":"2025-06-17","type":"deal","source":"WSJ","summary":"Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion - WSJ","headline":"Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNb3VFQzlLMTBHWkxIcWZmcWluSWh1T1gzWU8xa0tYdlQtOXBlcUdsTXlpSlBsSWtJdDJYWGVxZzNvVzBIdkwtTENXeWlyY2lCbDVzajM1LUFVWTYxNnlfQ2t0cmttVHFuUW1zNFVjQjBQZ1VNRVctMUMtb25iMTJEOTBjdjh5S00?oc=5","date":"2025-06-17","type":"pipeline","source":"Barron's","summary":"Verve Therapeutics Stock Soars 77% After Eli Lilly’s $1.3 Billion Bid - Barron's","headline":"Verve Therapeutics Stock Soars 77% After Eli Lilly’s $1.3 Billion Bid - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQOW5qZ18zNGNSUHBySUotdDBoQnpTSVczTTBuT1J1LTluUjFMOXNFOFhLSU05TzF5M2VCR0JjU2RCdlN1bW82cDBVTkJpOGJmOGF0WjFwNTE4bGJZNkFYQ3dQZ3ExRlVwN3ZrWklfcDRaa0lHRVFJVDdNT0VraWRyMEtTV2NIV1lzS3dqY2JMdw?oc=5","date":"2025-06-17","type":"deal","source":"upi.com","summary":"Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs - upi.com","headline":"Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPZzVhYUNUeHdad2tNT2R0OUk0QVIxUGQ4eGpKell1TklmdVBVRGJvVmplSVpNTlBMWVhoanRJOHAwTmw4WFpLLXMwWWpSTkJnNjE5aEpzdU1Odl80ODdQZVBodDBweURVS0VsdEhJVWdaWWxKM0oyRjhSMF96LUhUZTJjUkY2ZXYtX2c2VzNvNnpaUFVEZG9xc3R4Rm0?oc=5","date":"2025-06-17","type":"deal","source":"Bloomberg.com","summary":"Eli Lilly to Buy Gene-Editing Biotech Verve for $1.3 Billion - Bloomberg.com","headline":"Eli Lilly to Buy Gene-Editing Biotech Verve for $1.3 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNM2dFczh4Tl92VzJSTnlmbnhrV0tCTFl0UXFhWDdmWHBfWnpkLWhQckN2T25meXY5X092VXhLd1VVbFdIdDdsNTl2bDQ4YzdZVWNWb0NtZl9LRXBtOERPWUZDdW1fOWRXTllTUHJPRFkyWkxJZnlnVjZSOUtfcnNJNk9tNGZDTS1oMVNCcVpyLTZXa1J6alFEeXVB?oc=5","date":"2025-06-17","type":"deal","source":"BioPharma Dive","summary":"Lilly to acquire Verve in $1B bet on gene editing for heart disease - BioPharma Dive","headline":"Lilly to acquire Verve in $1B bet on gene editing for heart disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOa0dXZDVoVFpWbmxyQ214RVU3blJXb3RBcWpUUFZZYVBFamlNb21OUWdGR2hQUkNFTzFFT2RKT3diYXBuaEZweDBpWnRLd25BTzZ3Rm5US3BrXzlSbVJudTVweHoxZTVQMXNmdUU4U3E5V1dULTNVU25rOUowSFAwWU14TGFvcHF6b3lBeTNheVZRYVlLSEZDV1dtS1NNWHpjTFBUNXhDSQ?oc=5","date":"2025-06-17","type":"pipeline","source":"Investor's Business Daily","summary":"Eli Lilly Gets Into The Gene-Editing Space With $1 Billion Takeout - Investor's Business Daily","headline":"Eli Lilly Gets Into The Gene-Editing Space With $1 Billion Takeout - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-17","type":"deal","source":"Medical Dialogues","summary":"Eli Lilly to buy Verve Therapeutics for USD 1.3 billion - Medical Dialogues","headline":"Eli Lilly to buy Verve Therapeutics for USD 1.3 billion","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}